Dongming Xing
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Pharmacology top 1%
- Berberine and alkaloids research
- Flavonoids in Medical Research
Papers in
- Pharmacology 42
- Flavonoids in Medical Research 10
Dongming Xing
212 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 1.1k
- Pharmacology 844
- Molecular Biology 3.3k
- Complementary and alternative medicine 357
- Pharmacology 377
Countries citing papers authored by Dongming Xing
This map shows the geographic impact of Dongming Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongming Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongming Xing more than expected).
Fields of papers citing papers by Dongming Xing
This network shows the impact of papers produced by Dongming Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongming Xing. The network helps show where Dongming Xing may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongming Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 18 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 15 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 21 | |
| 13 | 2023 | 52 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 4 | |
| 16 | 2023 | 1 | |
| 17 | 2022 | 22 | |
| 18 | 2022 | 12 | |
| 19 | 2021 | 32 | |
| 20 | 2020 | 108 |
About Dongming Xing
Dongming Xing is a scholar working on Pharmacology, Complementary and alternative medicine, Molecular Biology, Pharmacology and Biological Psychiatry, having authored 220 papers that have together received 6.7k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (13 papers), Natural product bioactivities and synthesis (13 papers), Protein Degradation and Inhibitors (13 papers), Advanced biosensing and bioanalysis techniques (12 papers), Synthesis and biological activity (12 papers), Cholesterol and Lipid Metabolism (12 papers), Flavonoids in Medical Research (10 papers) and Nanoplatforms for cancer theranostics (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Pharmacology (844 citations), Molecular Biology (3.3k citations), Complementary and alternative medicine (357 citations) and Pharmacology (377 citations). Dongming Xing has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lijun Du, Wujun Chen, Zhimin Lu, Daqian Xu, Bing Liang, Rui Liu, Xueli Bian, Ying Meng, Yudong Wu and Rufeng Wang. Their work appears in journals such as Tsinghua Science & Technology, Biomedical Chromatography, Journal of Enzyme Inhibition and Medicinal Chemistry, European Journal of Medicinal Chemistry and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.